Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging

Current Neuropharmacology

Volumn 14, Issue , 2016, Pages

  Cutuli, Debora ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Aging; Cognitive decline; Morphometry; Neuroinflammation; Neuroplasticity; Omega 3 fatty acids

Indexed keywords

DOPAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; NORADRENALIN; OMEGA 3 FATTY ACID; PROSTAGLANDIN E; SEROTONIN; NEUROPROTECTIVE AGENT;

AGING; AMYGDALA; ASTROCYTOSIS; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; HUMAN; HYPERTRIGLYCERIDEMIA; MICROGLIA; MORPHOMETRY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; OXIDATIVE STRESS; REVIEW; ANIMAL; BRAIN; DRUG EFFECTS;

AGING; ANIMALS; BRAIN; FATTY ACIDS, OMEGA-3; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84994373144     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X14666160614091311     Document Type: Review

References (141)

1. Petrosini, L; Cutuli, D., De Bartolo, P. In: Handbook of Psychology, 2nd Ed.; Weiner, I.B., Ed.; John Wiley & Sons, Inc.: USA, 2013; Vol. 2, pp. 461-479.
2. Kino, T. Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders. Front. Physiol., 2015, 6, 230.
3. Sweatt, J.D. Hippocampal function in cognition. Psychopharmacology, 2004, 174, 99-110.
4. Yau, S.Y.; Li, A.; So, K.F. Involvement of adult hippocampal neurogenesis in learning and forgetting. Neural Plast., 2015, 717958.
5. Gruart, A.; Leal-Campanario, R.; López-Ramos, J.C.; Delgado-García, J.M. Functional basis of associative learning and their relationships with long-term potentiation evoked in the involved neural circuits: Lessons from studies in behaving mammals. Neurobiol. Learn. Mem., 2015, 124, 3-18.
6. Maren, S.; Baudry, M. Properties and mechanisms of longterm synaptic plasticity in the mammalian brain: relationships to learning and memory. Neurobiol. Learn. Mem., 1995, 63, 1-18.
7. Deng, W.; Aimone, J.B.; Gage, F.H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci., 2010, 11, 339-350.
8. Revest, J.M.; Dupret, D.; Koehl, M.; Funk-Reiter, C.; Grosjean, N.; Piazza, P.V.; Abrous, D.N. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol. Psychiatry, 2009, 14, 959-967.
9. Snyder, J.S.; Soumier, A.; Brewer, M.; Pickel, J.; Cameron, H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature, 2011, 476, 458-462.
10. Mu, Y.; Lee, S.W.; Gage, F.H. Signaling in adult neurogenesis. Curr. Opin. Neurobiol., 2010, 20, 416-423.
11. Palmer, T.D.; Willhoite, A.R.; Gage, F.H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol., 2000, 425, 479-494.
12. Villeda, S.A.; Luo, J.; Mosher, K.I.; Zou, B.; Britschgi, M.; Bieri, G.; Stan, T.M.; Fainberg, N.; Ding, Z.; Eggel, A.; Lucin, K.M.; Czirr, E.; Park, J.S.; Couillard-Després, S.; Aigner, L.; Li, G.; Peskind, E.R.; Kaye, J.A.; Quinn, J.F.; Galasko, D.R.; Xie, X.S.; Rando, T.A.; Wyss-Coray, T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature, 2011, 477, 90-94.
13. Ambrogini, P.; Lattanzi, D.; Ciuffoli, S.; Betti, M.; Fanelli, M.; Cuppini, R. Physical exercise and environment exploration affect synaptogenesis in adult-generated neurons in the rat dentate gyrus: possible role of BDNF. Brain Res., 2013, 1534, 1-12.
14. Beauquis, J.; Roig, P.; De Nicola, A.F.; Saravia, F. Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PLoS ONE, 2010, 5, e13993.
15. Huang, Y.F.; Yang, C.H.; Huang, C.C.; Hsu, K.S. Vascular endothelial growth factor-dependent spinogenesis underlies antidepressant-like effects of enriched environment. J. Biol. Chem., 2012, 287, 40938-40955.
16. Petrosini, L.; De Bartolo, P.; Foti, F.; Gelfo, F.; Cutuli, D.; Leggio, M.G.; Mandolesi, L. On whether the environmental enrichment may provide cognitive and brain reserves. Brain Res. Rev., 2009, 61, 221-239.
17. Kempermann, G. New neurons for ‘survival of the fittest’. Nature Rev. Neurosci., 2012, 13, 727-736.
18. McEwen, B.S.; Magarinos, A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol., 2001, 16, S7-S19.
19. Whiteman, A.S.; Young, D.E.; He, X.; Chen, T.C.; Wagenaar, R.C.; Stern, C.E.; Schon, K. Interaction between serum BDNF and aerobic fitness predicts recognition memory in healthy young adults. Behav. Brain Res., 2014, 259, 302-312.
20. Murphy, T.; Dias, G.P.; Thuret, S. Effects of diet on brain plasticity in animal and human studies: mind the gap. Neural Plast., 2014, 563160.
21. Draganski, B.; Lutti, A.; Kherif, F. Impact of brain aging and neurodegeneration on cognition: evidence from MRI. Curr. Opin. Neurol., 2013, 26, 640-645.
22. Harada, C.N.; Natelson Love, M.C.; Triebel, K.L. Normal cognitive aging. Clin. Geriatr. Med., 2013, 29, 737-752.
23. Brown DR. Role of microglia in age-related changes to the nervous system. ScientificWorldJournal. 2009 Oct 2; 9: 1061-71
24. Driscoll, I.; Howard, S.R.; Stone, J.C.; Monfils, M.H.; Tomanek, B.; Brooks, W.M.; Sutherland, R.J. The aging hippocampus: a multi-level analysis in the rat. Neuroscience, 2006, 139, 1173-1185.
25. Masliah, E.; Crews, L.; Hansen, L. Synaptic remodeling during aging and in Alzheimer’s disease. J. Alzheimers Dis., 2006, 9, 91-99.
26. Gomez-Pinilla, F. The influences of diet and exercise on mental health through hormesis. Ageing Res. Rev., 2008, 7, 49-62.
27. Maruszak, A.; Pilarski, A.; Murphy, T.; Branch, N.; Thuret, S. Hippocampal neurogenesis in Alzheimer’s disease: is there a role for dietary modulation? J. Alzheimers Dis., 2014, 38, 11-38.
28. Sinn, N.; Milte C.; Howe, P.R.C. Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients, 2010, 2, 128-170.
29. Yehuda, S.; Rabinovitz, S.; Carasso, R.L.; Mostofsky, D.I. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging, 2002, 23, 843-853.
30. Woo, J. Nutritional strategies for successful aging. Med. Clin. North Am., 2011, 95, 477-493.
31. Yehuda, S. Polyunsaturated fatty acids as putative cognitive enhancers. Med. Hypotheses, 2012, 79, 456-61.
32. Luchtman, D.W.; Song, C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology, 2013, 64, 550-565.
33. Denis I.; Potier, B.; Vancassel, S.; Heberden, C.; Lavialle, M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res. Rev., 2013, 12, 579-594.
34. Fotuhi, M.; Mohassel, P.; Yaffe, K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol., 2009, 5, 140-152.
35. Gómez-Pinilla, F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci., 2008, 9, 568-578.
36. Hooijmans, C.R.; Pasker-de Jong, P.C.; de Vries, R.B.; Ritskes-Hoitinga, M. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer’s pathology in animal models of Alzheimer’s disease: a systematic review and metaanalysis. J. Alzheimers Dis., 2012, 28, 191-209.
37. Sydenham, E.; Dangour, A.D.; Lim, W.S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst. Rev., 2012, 6, CD005379.
38. Fedorova, I.; Salem, N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot. Essent. Fatty Acids., 2006, 75, 271-289.
39. Cunnane, S.C.; Plourde, M.; Pifferi, F.; Bégin, M.; Féart, C.; Barberger-Gateau, P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog. Lipid Res., 2009, 48, 239-256.
40. Beydoun, M.A.; Kaufman, J.S.; Satia, J.A.; Rosamond, W.; Folsom, A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr., 2007, 85, 1103-1111.
41. Dullemeijer, C.; Durga, J.; Brouwer, I.A.; van de Rest, O.; Kok, F.J.; Brummer, R.J.; van Boxtel, M.P.; Verhoef, P. n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am. J. Clin. Nutr., 2007, 86, 1479-1485.
42. Heude, B.; Ducimetière, P.; Berr, C. Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA Study. Am. J. Clin. Nutr., 2003, 77, 803-808.
43. Kröger, E.; Verreault, R.; Carmichael, P.H.; Lindsay, J.; Julien, P.; Dewailly, E.; Ayotte, P.; Laurin, D. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am. J. Clin. Nutr., 2009, 90, 184-192.
44. Samieri, C.; Féart, C.; Proust-Lima, C.; Peuchant, E.; Dartigues, J.F.; Amieva, H.; Barberger-Gateau, P. ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression. Neurobiol. Aging, 2011, 32, 2317.e13-22.
45. Whalley, L.J.; Deary, I.J.; Starr, J.M.; Wahle, K.W.; Rance, K.A.; Bourne, V.J.; Fox, H.C. n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am. J. Clin. Nutr., 2008, 87, 449-454.
46. Bowman, G.L.; Silbert, L.C.; Howieson, D.; Dodge, H.H.; Traber, M.G.; Frei, B.; Kaye, J.A.; Shannon, J.; Quinn, J.F. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology, 2012, 78, 241-249.
47. Bowman, G.L.; Dodge, H.H.; Mattek, N.; Barbey, A.K.; Silbert, L.C.; Shinto, L.; Howieson, D.B.; Kaye, J.A.; Quinn, J.F. Plasma omega-3 PUFA and white matter mediated executive decline in older adults. Front. Aging Neurosci., 2013, 5, 92.
48. Pottala, J.V.; Yaffe, K.; Robinson, J.G.; Espeland, M.A.; Wallace, R.; Harris, W.S. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology, 2014, 82, 435-442.
49. Raji, C.A.; Erickson, K.I.; Lopez, O.L.; Kuller, L.H.; Gach, H.M.; Thompson, P.M.; Riverol, M.; Becker, J.T. Regular fish consumption and age-related brain gray matter loss. Am. J. Prev. Med., 2014, 47, 444-451.
50. Samieri, C.; Maillard, P.; Crivello, F.; Proust-Lima, C.; Peuchant, E.; Helmer, C.; Amieva, H.; Allard, M.; Dartigues, J.F.; Cunnane, S.C.; Mazoyer, B.M.; Barberger-Gateau, P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology, 2012, 79, 642-650.
51. Tan, Z.S.; Harris, W.S.; Beiser, A.S.; Au, R.; Himali, J.J.; Debette, S.; Pikula, A.; Decarli, C.; Wolf, P.A.; Vasan, R.S.; Robins, S.J.; Seshadri, S. Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology, 2012, 78, 658-664.
52. Titova, O.E.; Sjögren, P.; Brooks, S.J.; Kullberg, J.; Ax, E.; Kilander, L.; Riserus, U.; Cederholm, T.; Larsson, E.M.; Johansson, L.; Ahlström, H.; Lind, L.; Schiöth, H.B.; Benedict, C. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age (Dordr), 2013, 35, 1495-1505.
53. Virtanen, J.K.; Siscovick, D.S.; Lemaitre, R.N.; Longstreth, W.T.; Spiegelman, D.; Rimm, E.B.; King, I.B.; Mozaffarian, D. Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. J. Am. Heart Assoc., 2013, 2, e000305.
54. Dangour, A.D.; Allen, E.; Elbourne, D.; Fasey, N.; Fletcher, A.E.; Hardy, P.; Holder, G.E.; Knight, R.; Letley, L.; Richards, M.; Uauy, R. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr., 2010, 91, 1725-1732.
55. Danthiir, V.; Hosking, D.; Burns, N.R.; Wilson, C.; Nettelbeck, T.; Calvaresi, E.; Clifton, P.; Wittert, G.A. Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. J. Nutr., 2014, 144, 311-320.
56. Geleijnse, J.M.; Giltay, E.J.; Kromhout, D. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebocontrolled trial in stable myocardial infarction patients. Alzheimers Dement., 2012, 8, 278-287.
57. van de Rest, O.; Geleijnse, J.M.; Kok, F.J.; van Staveren, W.A.; Dullemeijer, C.; Olderikkert, M.G.; Beekman, A.T.; de Groot, C.P. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology, 2008, 71, 430-438.
58. Witte, A.V.; Kerti, L.; Hermannstädter, H.M.; Fiebach, J.B.; Schreiber, S.J.; Schuchardt, J.P.; Hahn, A.; Flöel, A. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb. Cortex, 2014, 24, 3059-3068.
59. Yurko-Mauro, K.; McCarthy, D.; Rom, D.; Nelson, E.B.; Ryan, A.S.; Blackwell, A.; Salem, N., Stedman, M.; MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement., 2010, 6, 456-464.
60. Dyall, S.C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci., 2015, 7, 52.
61. Su, H.M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J. Nutr. Biochem., 2010, 21, 364-373.
62. Dyall, S.C.; Michael, G.J.; Whelpton, R.; Scott, A.G.; Michael-Titus, A.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol. Aging, 2007, 83, 424-439.
63. Latour, A.; Grintal, B.; Champeil-Potokar, G.; Hennebelle, M.; Lavialle, M.; Dutar, P.; Potier, B.; Billard, J.M.; Vancassel, S.; Denis, I. Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1. Aging Cell., 2013, 12, 76-84.
64. Martin, D.S.; Spencer, P.; Horrobin, D.F.; Lynch, M.A. Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. Prostaglandins Leukot. Essent. Fatty Acids, 2002, 67, 121-30.
65. McGahon, B.M.; Martin, D.S.; Horrobin, D.F.; Lynch, M.A. Agerelated changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience, 1999, 941, 305-14.
66. Kelly, L.; Grehan, B.; Chiesa, A.D.; O’Mara, S.M.; Downer, E.; Sahyoun, G.; Massey, K.A.; Nicolaou, A.; Lynch, M.A. The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol. Aging, 2011, 32, 2318.e1-15.
67. Costa, V.; Lugert, S.; Jagasia, R. Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers. Handb. Exp. Pharmacol., 2015, 228, 99-155.
68. DeCarolis, N.A.; Kirby, E.D.; Wyss-Coray, T.; Palmer, T.D. The Role of the Microenvironmental Niche in Declining Stem-Cell Functions Associated with Biological Aging. Cold Spring Harb. Perspect. Med., 2015, 5, pii: a025874.
69. Kawakita, E.; Hashimoto, M.; Shido, O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience, 2006, 1393, 991-997.
70. Dyall, S.C.; Michael, G.J.; Michael-Titus, A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J. Neurosci. Res., 2010, 88, 2091-2102.
71. Robson, L.G.; Dyall, S.; Sidloff, D.; Michael-Titus, A.T. Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol. Aging, 2010, 31, 678-687.
72. Tokuda, H.; Kontani, M.; Kawashima, H.; Kiso, Y.; Shibata, H.; Osumi, N. Differential effect of arachidonic acid and docosahexaenoic acid on age-related decreases in hippocampal neurogenesis. Neurosci. Res., 2014, 88, 58-66.
73. Cutuli, D.; De Bartolo, P.; Caporali, P.; Laricchiuta, D.; Foti, F.; Ronci, M.; Rossi, C.; Neri, C.; Spalletta, G.; Caltagirone, C.; Farioli-Vecchioli, S.; Petrosini L. n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front. Aging Neurosci., 2014, 6, 220.
74. Feher, J.; Kovacs, B.; Kovacs, I.; Schveoller, M.; Papale, A.; Balacco Gabrieli, C. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica, 2005, 219, 154-166.
75. Liu, J.; Head, E.; Gharib, A.M.; Yuan, W.; Ingersoll, R.T.; Hagen, T.M.; Cotman, C.W.; Ames, B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or Ralpha-lipoic acid. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 2356-2361.
76. Janssen, C.I.; Kiliaan, A.J. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog. Lipid Res., 2014, 53, 1-17.
77. Jiang, L.H.; Shi, Y.; Wang, L.S.; Yang, Z.R. The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. J. Nutr. Biochem., 2009, 20, 735-741.
78. He, C.; Qu, X.; Cui, L.; Wang, J.; Kang, J.X. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 11370-11375.
79. Hussain, G.; Schmitt, F.; Loeffler, J.P.; Gonzalez de Aguilar, J.L. Fatting the brain: a brief of recent research. Front. Cell. Neurosci., 2013, 7: 144.
80. Labrousse, V.F.; Nadjar, A.; Joffre, C.; Costes, L.; Aubert, A.; Grégoire, S.; Bretillon, L.; Layé, S. Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS One, 2012, 7, e36861.
81. González-Ramírez, M.M.; Velázquez-Zamora, D.A.; Olvera-Cortés, M.E.; González-Burgos, I. Changes in the plastic properties of hippocampal dendritic spines underlie the attenuation of place learning in healthy aged rats. Neurobiol. Learn. Mem., 2014, 109, 94-103.
82. Jacobs, B.; Driscoll, L.; Schall, M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol., 1997, 3864, 661-680.
83. Markham, J.A.; Juraska, J.M. Aging and sex influence the anatomy of the rat anterior cingulate cortex. Neurobiol. Aging, 2002, 234, 579-588.
84. Sakamoto, T.; Cansev, M.; Wurtman, R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res., 2007, 1182, 50-59.
85. Capuron, L.; Miller, A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther., 2011, 130, 226-238.
86. Johnson, R.W. Feeding the beast: can microglia in the senescent brain be regulated by diet? Brain Behav. Immun., 2015, 43, 1-8.
87. Layé, S. What do you eat? Dietary omega 3 can help to slow the aging process. Brain Behav. Immun., 2013, 28, 14-15.
88. Bazinet, R.P.; Layé, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci., 2014, 15, 771-785.
89. Hibbeln, J.R.; Nieminen, L.R.G.; Blasbalg, T.L.; Riggs, J.A.; Lands, W.E.M. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr., 2006, 83, 1483S-1493S.
90. Lands, W.E. Dietary Fat and Health: The Evidence and the Politics of Prevention: Careful Use of Dietary Fats Can Improve Life and Prevent Disease. Ann. N. Y. Acad. Sci., 2005, 1055, 179-192.
91. Okuyama, H.; Ichikawa, Y.; Sun, Y.; Hamazaki, T.; Lands, W.E.M. Omega3 fatty acids effectively prevent coronary heart disease and other late-onset diseases-the excessive linoleic acid syndrome. World Rev. Nutr. Diet, 2007, 96, 83-103.
92. Simopoulos, A.P. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol. Neurobiol., 2011, 44, 203-215.
93. Farzaneh-Far, R.; Harris, W.S.; Garg, S.; Na, B.; Whooley, M.A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis, 2009, 205, 538-543.
94. Ferrucci, L.; Cherubini, A.; Bandinelli, S.; Bartali, B.; Corsi, A.; Lauretani, F.; Martin, A.; Andres-Lacueva, C.; Senin, U.; Guralnik, J.M. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab., 2006, 91, 439-446.
95. Kalogeropoulos, N.; Panagiotakos, D.B.; Pitsavos, C.; Chrysohoou, C.; Rousinou, G.; Toutouza, M.; Stefanadis, C. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin. Chim. Acta, 2010, 411, 584-591.
96. Kiecolt-Glaser, J.K.; Belury, M.A.; Porter, K.; Beversdorf, D.Q.; Lemeshow, S.; Glaser, R. Depressive symptoms, omega-6: omega-3 fatty acids, and inflammation in older adults. Psychosom. Med., 2007, 69, 217-224.
97. Farzaneh-Far, R.; Lin, J.; Epel, E.S.; Harris, W.S.; Blackburn, E.H.; Whooley, M.A. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. J. A. M. A., 2010, 303, 250-257.
98. Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS, Blackburn E. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun. 2013 Feb; 28: 16-24.
99. O’Callaghan, N.; Parletta, N.; Milte, C.M.; Benassi-Evans, B.; Fenech, M.; Howe, P.R. Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study. Nutrition, 2014, 30, 489-491.
100. Orr, S.K.; Trepanier, M.O.; Bazinet, R.P. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins leukot essent fatty acids, 2013, 88, 97-103.
101. Lynch, A.M.; Loane, D.J.; Minogue, A.M.; Clarke, R.M.; Kilroy, D.; Nally, R.E.; Roche, O.J.; O’Connell, F.; Lynch, M.A. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol. Aging, 2007, 286, 845-855.
102. Maher, F.O.; Martin, D.S.; Lynch, M.A. Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase. Neurobiol. Aging, 2004, 25, 795-806.
103. Martin, D.S.; Lonergan, P.E.; Boland, B.; Fogarty, M.P.; Brady, M.; Horrobin, D.F.; Campbell, V.A.; Lynch, M.A. Apoptotic changes in the aged brain are triggered by interleukin-1betainduced activation of p38 and reversed by treatment with eicosapentaenoic acid. J. Biol Chem., 2002, 277, 34239-34246.
104. Kaur, M.; Sharma, S.; Kaur, G. Age-related impairments in neuronal plasticity markers and astrocytic GFAP and their reversal by late-onset short term dietary restriction. Biogerontology, 2008, 9, 441-454.
105. Lynch, A.M.; Murphy, K.J.; Deighan, B.F.; O’Reilly, J.A.; Gun'ko, Y.K.; Cowley, T.R.; Gonzalez-Reyes, R.E.; Lynch, M.A. The impact of glial activation in the aging brain. Aging Dis., 2010, 1, 262-278.
106. Weinstock, M.; Luques, L.; Poltyrev, T.; Bejar, C.; Shoham, S. Ladostigil prevents age-related glial activation and spatial memory deficits in rats. Neurobiol. Aging, 2011, 32, 1069-1078.
107. Haley, G.E.; Kohama, S.G.; Urbanski, H.F.; Raber, J. Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus. Age (Dordr), 2010, 32, 283-296.
108. Middeldorp, J.; Hol, E.M. GFAP in health and disease. Prog. Neurobiol., 2011, 93, 421-443.
109. Potier, B.; Billard, J.M.; Rivière, S.; Sinet, P.M.; Denis, I.; Champeil-Potokar, G.; Grintal, B.; Jouvenceau, A.; Kollen, M.; Dutar, P. Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats. Aging Cell, 2010, 9, 722-735.
110. Layé, S. Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot. Essent. Fatty Acids, 2010, 82, 295-303.
111. Trépanier, M.O.; Hopperton, K.E.; Orr, S.K.; Bazinet, R.P. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update. Eur. J. Pharmacol., 2015, pii: S0014-2999 (15) 30043-1.
112. Bazan, N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol., 2005, 32, 89-103.
113. Lukiw, W.J.; Bazan, N.G. Docosahexaenoic acid and the aging brain. J. Nutr., 2008, 138, 2510-2514.
114. Pomponi, M.; Di Gioia, A.; Bria, P.; Pomponi, M.F. Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer’s type? Curr. Alzheimer Res., 2008, 5, 422-431
115. Gomez-Pinilla, F.; Tyagi, E. Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr. Opin. Clin. Nutr. Metab. Care, 2013, 16, 726-733.
116. Gómez-Pinilla, F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci., 2008, 9, 568-578.
117. Praticò, D. Lipid peroxidation and the aging process. Sci. Aging Knowledge Environ., 2002, 8, re5.
118. Chiurchiù, V., Maccarrone, M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox. Signal., 2011, 15, 2605-2641.
119. Chiurchiù, V., Orlacchio, A., Maccarrone, M. Is Modulation of Oxidative Stress an Answer? The state of the art of redox therapeutic actions in neurodegenerative diseases. Oxid. Med. Cell. Longev., 2016, 2016: 7909380.
120. Agrawal, R.; Gomez-Pinilla, F. 'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J. Physiol., 2012, 590, 2485-2499.
121. Gamoh, S., Hashimoto, M., Hossain, S., Masumura, S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin. Exp. Pharmacol. Physiol., 2001, 28, 266-270.
122. Hashimoto, M.; Katakura, M.; Tanabe, Y.; Al Mamun, A.; Inoue, T.; Hossain, S.; Arita, M.; Shido, O. n-3 fatty acids effectively improve the reference memory-related learning ability associated with increased brain docosahexaenoic acid-derived docosanoids in aged rats. Biochim. Biophys. Acta, 2015, 1851, 203-209.
123. Puca, A.A.; Andrew, P.; Novelli, V.; Anselmi, C.V.; Somalvico, F.; Cirillo, N.A.; Chatgilialoglu, C.; Ferreri, C. Fatty acid profile of erythrocyte membranes as possible biomarker of longevity. Rejuvenation Res., 2008, 11, 63-72.
124. Lee, L.K.; Shahar, S.; Rajab, N.; Yusoff, N.A.; Jamal, R.A.; Then, S.M. The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study. J. Nutr. Biochem., 2013, 24, 803-808.
125. Mabile, L.; Piolot, A.; Boulet, L.; Fortin, L.J.; Doyle, N.; Rodriguez, C.; Davignon, J.; Blache, D.; Lussier-Cacan, S. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am. J. Clin. Nutr., 2001, 74, 449-456.
126. Mori, T.A.; Woodman, R.J.; Burke, V.; Puddey, I.B.; Croft, K.D.; Beilin, L.J. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treatedhypertensive type 2 diabetic subjects. Free Radic. Biol. Med., 2003, 35, 772-781.
127. Julia, C.; Touvier, M.; Meunier, N.; Papet, I.; Galan, P.; Hercberg, S.; Kesse-Guyot, E. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier. J. Nutr., 2013, 143, 1760-1766.
128. Fjell, A.M.; Walhovd, K.B. Structural brain changes in aging: courses, causes and cognitive consequences. Rev. Neurosci., 2010, 21, 187-221.
129. McNamara, R.K. DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. J. Nutr., 2010, 140, 864-868.
130. Conklin, S.M.; Gianaros, P.J.; Brown, S.M.; Yao, J.K.; Hariri, A.R.; Manuck, S.B.; Muldoon, M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Letters., 2007, 421, 209-212.
131. Cutuli, D.; Pagani, M.; Caporali, P.; Galbusera, A.; Laricchiuta, D.; Foti, F.; Neri, C.; Spalletta, G.; Caltagirone, C.; Petrosini, L.; Gozzi, A. Effects of omega-3 fatty acid supplementation on cognitive functions and neural substrates: a voxel-based morphometry study in aged mice. Front. Aging Neurosci., 2016, 8, 38.
132. Puri, B.K.; Counsell, S.J.; Hamilton, G.; Richardson, A.J.; Horrobin, D.F. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int. J. Clin. Pract., 2001, 55, 560-563.
133. Schipper, P.; Kiliaan, A.J.; Homberg, J.R. A mixed polyunsaturated fatty acid diet normalizes hippocampal neurogenesis and reduces anxiety in serotonin transporter knockout rats. Behav Pharmacol., 2011, 22, 324-334.
134. Lang, U.E.; Borgwardt, S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem., 2013, 31, 761-777.
135. Erickson, K.I.; Miller, D.L.; Roecklein, K.A. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist, 2012, 18, 82-97.
136. Vu, N.Q.; Aizenstein, H.J. Depression in the elderly: brain correlates, neuropsychological findings, and role of vascular lesion load. Curr Opin Neurol., 2013, 26, 656-661.
137. Su, K.P. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? Neurosignals, 2009, 17, 144-152.
138. Gomez-Pinilla, F.; Gomez, A.G. The influence of dietary factors in central nervous system plasticity and injury recovery. P.M. R., 2011, 3, S111-S116.
139. Köbe, T.; Witte, A.V.; Schnelle, A.; Lesemann, A.; Fabian, S.; Tesky, V.A.; Pantel, J.; Flöel, A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage, 2015, pii, S1053-8119 (15) 00872-1.
140. Barceló-Coblijn, G.; Högyes, E.; Kitajka, K.; Puskás, L.G.; Zvara, A.; Hackler, L.; Nyakas, C.; Penke, Z.; Farkas, T. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 11321-11326.
141. Quinn, J.F.; Raman, R.; Thomas, R.G.; Yurko-Mauro, K.; Nelson, E.B.; Van Dyck, C.; Galvin, J.E.; Emond, J.; Jack, C.R.; Weiner, M.; Shinto, L.; Aisen, P.S. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. J. A. M. A., 2010, 304, 1903-1911.